Silencing of DLGAP5 by siRNA Significantly Inhibits the Proliferation and Invasion of Hepatocellular Carcinoma Cells

• Weijia Liao ,

  Contributed equally to this work with: Weijia Liao, Weilong Liu

  Affiliation Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China

  ⨯
• Weilong Liu ,

  Contributed equally to this work with: Weijia Liao, Weilong Liu

  Affiliation Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China

  ⨯
• Qing Yuan,

  Affiliation Shanghai-MOST Key Laboratory for Disease and Health Genomics, National Engineering Center for Biochip at Shanghai, Shanghai, China

  ⨯
• Xing Liu,

  Affiliation Shanghai-MOST Key Laboratory for Disease and Health Genomics, National Engineering Center for Biochip at Shanghai, Shanghai, China

  ⨯
• Ying Ou,

  Affiliation Shanghai-MOST Key Laboratory for Disease and Health Genomics, National Engineering Center for Biochip at Shanghai, Shanghai, China

  ⨯
• Songqing He,

  Affiliation Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China

  ⨯
• Shengguang Yuan,

  Affiliation Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China

  ⨯
• Liling Qin,

  Affiliation Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China

  ⨯
• Qian Chen,

  Affiliation Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China

  ⨯
• Kate Nong,

  Affiliation Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China

  ⨯
• Minghui Mei,

  Affiliation Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China

  ⨯
• Jian Huang

  * E-mail: huangjchgc@hotmail.com

  Affiliations Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People’s Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China, Guangdong Key Laboratory of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China, Shanghai-MOST Key Laboratory for Disease and Health Genomics, National Engineering Center for Biochip at Shanghai, Shanghai, China

  ⨯